Novacyt Group: PathFlow® technology and knowledge underpin our drive for continued innovation
Advancing technology and a unique wealth of knowledge are the driving forces behind innovative development in our PathFlow® portfolio of diagnostic tests for infectious diseases. Our latest addition to the range – the PathFlow® SARS-CoV-2 IgG – is an easy-to-use, rapid, lateral flow test for the detection of COVID-19 antibodies. It’s a natural evolution in the Novacyt Group’s range of COVID-19 diagnostic solutions, building on our growing expertise in this field, plus our ability to maximise the potential of our technologies [...]